Hydromorphone in Pediatric Pain Management: Pharmacology, Clinical Applications, and Safety Considerations—A Narrative Review
Authors:
- Alessandro VittoriAlessandro Vittori
- Cecilia Di FabioCFCecilia Di Fabio
- Ilaria MasciliniIMIlaria Mascilini
- Elisa FranciaEFElisa Francia
- Sara PescatoreSPSara Pescatore
- Corrado CecchettiCCCorrado Cecchetti
- Giuliano MarchettiGMGiuliano Marchetti
- Franco MarinangeliFMFranco Marinangeli
- Teresa Grimaldi CapitelloTCTeresa Grimaldi Capitello
- Marco CascellaMCMarco Cascella
Open Access
- 22 July 2026
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2228
Abstract
Background: Pain is one of the most common and challenging clinical problems in pediatric care, affecting up to three-quarters of hospitalized children. Hydromorphone has gained increasing clinical interest as an alternative opioid in pediatric settings, although evidence supporting its use remains limited. Methods: A narrative literature review was conducted in accordance with SANRA recommendations using PubMed, Embase, and the Cochrane Library to identify studies evaluating hydromorphone use in pediatric and adolescent patients across perioperative, postoperative, intensive care unit (ICU), and emergency settings. Results: Available evidence suggests that hydromorphone may provide effective analgesia in pediatric patients across multiple clinical contexts, including postoperative pain control, patient-controlled analgesia, analgosedation in the ICU, and acute pain management in the emergency department. However, the available data are largely derived from small, heterogeneous, and predominantly retrospective studies, often limited to single-center experiences. Conclusions: Hydromorphone may represent a useful alternative opioid for pediatric pain management and analgosedation, particularly when morphine is ineffective or poorly tolerated. Nevertheless, the current evidence base is limited, heterogeneous, and largely observational, precluding robust conclusions regarding its comparative effectiveness and safety. Further well-designed pediatric studies are required to better define its role in clinical practice.Keywords
Funding Information
- Ministero della Salute
This publication has 99 references indexed in Scilit:
- Off-label use of drugs in pediatrics: a scoping reviewEuropean Journal of Pediatrics, 2022
- “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in CanadaInternational Journal of Drug Policy, 2022
- Clinical management in an evidence vacuum: pharmacological management of children with persistent painCochrane Database of Systematic Reviews, 2019
- Intranasal hydromorphone for treatment of acute pain in children: A pilot studyThe American Journal of Emergency Medicine, 2019
- Erratum to: Why I Hate the Index FingerHAND, 2011
- Impact of an Emergency Department Pain Management Protocol on the Pattern of Visits by Patients with Sickle Cell DiseaseThe Journal of Emergency Medicine, 2007
- Hydromorphone metabolite accumulation in renal failureJournal of Pain and Symptom Management, 1995
- Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsPain, 1994
- The costs of managing severe cancer pain and potential savings from transdermal administrationEuropean Journal of Cancer, 1994
- Opioid hyperexcitability: the application of alternate opioid therapyPain, 1993